EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT
480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Number of Employees: 123
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.